STATE-OF-THE-ART PAPER
Clinical and genetic issues in familial dilated cardiomyopathy
Emily L. Burkett, MS, CGC and
Ray E. Hershberger, MD, FACC*
Division of Cardiology, Department of Medicine, Oregon Health and Science University, Portland, Oregon
Manuscript received July 2, 2004;
revised manuscript received September 16, 2004,
accepted November 22, 2004.
* Reprint requests and correspondence: Dr. Ray E. Hershberger, Division of Cardiology, UHN-62, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239
(Email: hershber{at}ohsu.edu). (URL: www.fdc.to).
Idiopathic dilated cardiomyopathy (IDC) is characterized by left ventricular dilatation and systolic dysfunction after known causes have been excluded. Idiopathic dilated cardiomyopathy occurring in families, or familial dilated cardiomyopathy (FDC), may occur in 20% to 50% of IDC cases. Sixteen genes have been shown to cause autosomal dominant FDC, but collectively may account for only a fraction of genetic causation; it is anticipated that additional genes causative of FDC will be discovered. Familial dilated cardiomyopathy demonstrates incomplete penetrance, variable expression, and significant locus and allelic heterogeneity, making clinical and genetic diagnosis complex. Echocardiographic and electrocardiographic screening of first-degree relatives of individuals with IDC and FDC is indicated, as detection and treatment are possible before the onset of advanced symptomatic disease. Genetic counseling for IDC and FDC is also indicated to assist with family evaluations for genetic disease and with the uncertainty and anxiety surrounding the significance of clinical and genetic evaluation. Genetic testing is not yet commonly available, but its emergence will provide new opportunities for presymptomatic diagnosis.
|
Abbreviations and Acronyms
| | AD = autosomal dominant | | CK = creatine kinase | | CLIA = Clinical Laboratories Improvement Act | | DCM = dilated cardiomyopathy | | ECG = electrocardiography | | FDC = familial dilated cardiomyopathy | | HCM = hypertrophic cardiomyopathy | | HF = heart failure | | IDC = idiopathic dilated cardiomyopathy | | LVE = left ventricular enlargement |
|
This article has been cited by other articles:
|
|
|
|
 
R. E. Hershberger, J. Cowan, A. Morales, and J. D. Siegfried
Progress With Genetic Cardiomyopathies: Screening, Counseling, and Testing in Dilated, Hypertrophic, and Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Circ Heart Fail,
May 1, 2009;
2(3):
253 - 261.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R M Campbell, S Berger, and J Drezner
Sudden cardiac arrest in children and young athletes: the importance of a detailed personal and family history in the pre-participation evaluation
Br. J. Sports Med.,
May 1, 2009;
43(5):
336 - 341.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Jerosch-Herold, D. C. Sheridan, J. D. Kushner, D. Nauman, D. Burgess, D. Dutton, R. Alharethi, D. Li, and R. E. Hershberger
Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy
Am J Physiol Heart Circ Physiol,
September 1, 2008;
295(3):
H1234 - H1242.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Lombardi, A. Bell, V. Senthil, J. Sidhu, M. Noseda, R. Roberts, and A. J. Marian
Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies
Cardiovasc Res,
July 1, 2008;
79(1):
109 - 117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. D. Schocken, E. J. Benjamin, G. C. Fonarow, H. M. Krumholz, D. Levy, G. A. Mensah, J. Narula, E. S. Shor, J. B. Young, and Y. Hong
Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group
Circulation,
May 13, 2008;
117(19):
2544 - 2565.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Braunwald
The Management of Heart Failure: The Past, the Present, and the Future
Circ Heart Fail,
May 1, 2008;
1(1):
58 - 62.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Elliott, B. Andersson, E. Arbustini, Z. Bilinska, F. Cecchi, P. Charron, O. Dubourg, U. Kuhl, B. Maisch, W. J. McKenna, et al.
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Eur. Heart J.,
January 2, 2008;
29(2):
270 - 276.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Wiersma, P. Stabej, P. A. J. Leegwater, B. A. Van Oost, W. E. Ollier, and J. Dukes-McEwan
Evaluation of 15 Candidate Genes for Dilated Cardiomyopathy in the Newfoundland Dog
J. Hered.,
January 1, 2008;
99(1):
73 - 80.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. F. Padera Jr. and F. J. Schoen
Pathology of Cardiac Surgery
Card. Surg. Adult,
January 1, 2008;
3(2008):
111 - 178.
[Full Text]
|
|
|
|
|
|
|
N. H. Robin, P. B. Tabereaux, R. Benza, and B. R. Korf
Genetic Testing in Cardiovascular Disease
J. Am. Coll. Cardiol.,
August 21, 2007;
50(8):
727 - 737.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Ashrafian and H. Watkins
Reviews of Translational Medicine and Genomics in Cardiovascular Disease: New Disease Taxonomy and Therapeutic Implications: Cardiomyopathies: Therapeutics Based on Molecular Phenotype
J. Am. Coll. Cardiol.,
March 27, 2007;
49(12):
1251 - 1264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R.G. Taylor, D. Slavov, L. Ku, A. Di Lenarda, G. Sinagra, E. Carniel, K. Haubold, M. M. Boucek, D. Ferguson, S. L. Graw, et al.
Prevalence of Desmin Mutations in Dilated Cardiomyopathy
Circulation,
March 13, 2007;
115(10):
1244 - 1251.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Perrot, R. Dietz, and K. J. Osterziel
Is there a common genetic basis for all familial cardiomyopathies?
Eur J Heart Fail,
January 1, 2007;
9(1):
4 - 6.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. P. Donahue, D. A. Marchuk, and H. A. Rockman
Redefining Heart Failure: The Utility of Genomics
J. Am. Coll. Cardiol.,
October 3, 2006;
48(7):
1289 - 1298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Charron
Clinical genetics in cardiology.
Heart,
August 1, 2006;
92(8):
1172 - 1176.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Song, S. R. DePalma, M. Kharlap, A. G. Zenovich, A. Cirino, R. Mitchell, B. McDonough, B. J. Maron, C. E. Seidman, J.G. Seidman, et al.
Novel Locus for an Inherited Cardiomyopathy Maps to Chromosome 7
Circulation,
May 9, 2006;
113(18):
2186 - 2192.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. Peddy, L. A. Vricella, J. E. Crosson, G. L. Oswald, R. D. Cohn, D. E. Cameron, D. Valle, and B. L. Loeys
Infantile Restrictive Cardiomyopathy Resulting From a Mutation in the Cardiac Troponin T Gene
Pediatrics,
May 1, 2006;
117(5):
1830 - 1833.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Maron, J. A. Towbin, G. Thiene, C. Antzelevitch, D. Corrado, D. Arnett, A. J. Moss, C. E. Seidman, and J. B. Young
Contemporary Definitions and Classification of the Cardiomyopathies: An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention
Circulation,
April 11, 2006;
113(14):
1807 - 1816.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. Hershberger
Reply
J. Am. Coll. Cardiol.,
February 7, 2006;
47(3):
690 - 690.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Poller, H.-P. Schultheiss, and U. Kuhl
Viruses and Other Environmental Factors as Possible Sources of Phenotypic Heterogeneity in Familial Dilated Cardiomyopathy
J. Am. Coll. Cardiol.,
February 7, 2006;
47(3):
689 - 690.
[Full Text]
[PDF]
|
|
|
|
